is semaglutide banned by wada Critics are debating whether GLP-1 drugs should be in sports for potentially being performance-enhancing drugs. (Photo: Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) WADA's Flawed Reporting Limits Regime

Here are some examples

Clinical studies have shown that GLP-1 medications may help support metabolic health during the menopause transition by improving metabolic stability and supporting blood sugar control

Essential Baseline Assessment Depending on the treatment indication and medical history, a baseline assessment may include: Hemoglobin A1C Glucose Test Comprehensive Metabolic Panel Lipid Panel Complete Blood Count when clinically appropriate Kidney Profile or urine albumin-to-creatinine testing for relevant diabetes or kidney risk Early Follow-Up Follow-up may be considered after treatment initiation, dose escalation, or a clinically meaningful change in symptoms

They were not FDA-regulated

Inform your provider about the switch so they can update your records